Home
News
Create
Screeners
Insights
Aakaar Medical Technologies
70.
80
-3.70
(-4.97%)
Market Cap
₹100.34 Cr
PE Ratio
-
Industry
Consumer Goods
Buy
Sell
Company Performance:
1D
-4.97%
1M
+29.91%
6M
-5.47%
1Y
-0.63%
5Y
-0.63%
View Company Insights
Latest news about Aakaar Medical Technologies
Aakaar Medical FY26 PAT rises to ₹663.76 lakh
7 days ago
Aakaar Medical Technologies Limited announced its audited financial results for the year ended March 31, 2026, reporting a net profit of ₹663.76 lakh, up from ₹603.20 lakh in the previous year. Revenue from operations increased to ₹6,696.41 lakh from ₹6,158.28 lakh in FY25. The Board of Directors approved the results and the re-appointment of Mr. Dilip Ramesh Meswani as Non-Independent Director, subject to shareholder and SEBI approval. Statutory auditors M/s. C.B. Mehta & Associates issued an unmodified opinion on the financial statements.
Aakaar Medical approves ESOP 2026, hikes share capital
May 26, 2026
Aakaar Medical fixes record date for 13th AGM
May 22, 2026
Aakaar Medical Technologies to Set Up Aesthetics Device Manufacturing Facility in Pune
May 16, 2026
Aakaar Medical Technologies Appoints M/s. NAM & ASSOCIATES as Secretarial Auditors for Five-Year Term
May 16, 2026
More news about Aakaar Medical Technologies
15
May 26
Aakaar Medical Technologies Updates Code of Fair Disclosure Under SEBI Insider Trading Regulations
Aakaar Medical Technologies Limited's Board approved the revision of its Code of Practices and Procedures for Fair Disclosure of UPSI on May 14, 2026, under Regulation 8(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. The policy, originally adopted on December 19, 2024 and now carrying Revision 01/2026, sets out principles for uniform UPSI dissemination, analyst interactions, compliance officer duties, and digital database maintenance. An accompanying Annexure A outlines the Policy for Determination of Legitimate Purposes for sharing UPSI. The revised code is publicly available on the company's official website.
10
May 26
Aakaar Medical Technologies Submits Structured Digital Database Compliance Certificate for Financial Year Ended March 31, 2026
Aakaar Medical Technologies Limited submitted its SDD compliance certificate for the financial year ended March 31, 2026, to the National Stock Exchange of India on May 09, 2026. Certified by Devendra V Deshpande of DVD & Associates, the certificate confirms all 52 required UPSI events were captured and no non-compliance was observed. A temporary technical issue in the SDD during February 2026 was resolved promptly, with no data loss or integrity concerns, and the matter was noted by the Audit Committee.
08
May 26
Aakaar Medical Technologies Schedules H2 & FY26 Earnings Call for May 15, 2026
Aakaar Medical Technologies Limited has scheduled its H2 & FY26 earnings conference call for May 15, 2026, at 4:30 PM IST, following the Board's approval of audited financial results for the year ended March 31, 2026. The call, organised by Go India Advisors, will feature Founder & MD Dilip Meswani, CEO Rahul Sawakhande, and CFO Rakesh Parekh, with pre-registration mandatory for dial-in access. The intimation was filed under SEBI Regulation 30 and submitted to NSE on May 07, 2026.
Aakaar Medical Technologies
70.
80
-
3.
70
(-
4.
97
%)
1 Year Returns:
-0.63%
Industry Peers
Godrej Consumer Products
998.00
(+
0.
26
%)
Dabur India
424.15
(-
0.
12
%)
Colgate Palmolive
1,999.50
(-
0.
24
%)
P&G Hygiene and Health Care
9,400.00
(-
0.
53
%)
Gillette
7,763.00
(+
0.
73
%)
Cupid
137.10
(+
3.
01
%)
Emami
384.80
(-
1.
51
%)
Mamaearth
416.10
(-
0.
23
%)
Bajaj Consumer Care
552.05
(-
1.
21
%)
Anondita Medicare
1,219.90
(+
2.
90
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar